GB0814065D0 - Use of nucleoside analogs as anti-koi herpes virus molecules - Google Patents

Use of nucleoside analogs as anti-koi herpes virus molecules

Info

Publication number
GB0814065D0
GB0814065D0 GBGB0814065.9A GB0814065A GB0814065D0 GB 0814065 D0 GB0814065 D0 GB 0814065D0 GB 0814065 A GB0814065 A GB 0814065A GB 0814065 D0 GB0814065 D0 GB 0814065D0
Authority
GB
United Kingdom
Prior art keywords
herpes virus
nucleoside analogs
koi herpes
virus molecules
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0814065.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Universite de Liege
Original Assignee
Katholieke Universiteit Leuven
Universite de Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven, Universite de Liege filed Critical Katholieke Universiteit Leuven
Priority to GBGB0814065.9A priority Critical patent/GB0814065D0/en
Publication of GB0814065D0 publication Critical patent/GB0814065D0/en
Priority to PCT/EP2009/060039 priority patent/WO2010012840A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0814065.9A 2008-08-01 2008-08-01 Use of nucleoside analogs as anti-koi herpes virus molecules Ceased GB0814065D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0814065.9A GB0814065D0 (en) 2008-08-01 2008-08-01 Use of nucleoside analogs as anti-koi herpes virus molecules
PCT/EP2009/060039 WO2010012840A1 (en) 2008-08-01 2009-08-03 Use of nucleoside analogs as anti-koi herpes virus molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0814065.9A GB0814065D0 (en) 2008-08-01 2008-08-01 Use of nucleoside analogs as anti-koi herpes virus molecules

Publications (1)

Publication Number Publication Date
GB0814065D0 true GB0814065D0 (en) 2008-09-10

Family

ID=39767338

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0814065.9A Ceased GB0814065D0 (en) 2008-08-01 2008-08-01 Use of nucleoside analogs as anti-koi herpes virus molecules

Country Status (2)

Country Link
GB (1) GB0814065D0 (en)
WO (1) WO2010012840A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2487241A1 (en) 2011-02-09 2012-08-15 Westfälische Wilhelms-Universität Münster RNAi agents and compositions useful as carp therapeutics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69230349T2 (en) * 1991-03-05 2000-07-27 Ajinomoto Kk Cyclopropane derivative
TW282470B (en) * 1993-11-18 1996-08-01 Ajinomoto Kk

Also Published As

Publication number Publication date
WO2010012840A1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
HUS2000055I1 (en) 1' -substituted carba-nucleoside analogs for antiviral treatment
ZA201104638B (en) Nucleoside analogs
IL213701A0 (en) Synthesis of purine nucleosides
IL208313A0 (en) Neutralizing molecules to viral antigens
HK1209129A1 (en) Novel 7-deazapurine nucleosides for therapeutic uses 7-
EP2619215A4 (en) Azido nucleosides and nucleotide analogs
ZA201106827B (en) Substituted nucleoside and nucleotide analogs
SI2231689T1 (en) Novel cytostatic 7-deazapurine nucleosides
ZA201003234B (en) Use of oligonucleotides with modified bases as antiviral agents
EP2334328A4 (en) Methods for purification of viruses
ZA201102945B (en) Biocatalytic preparation of nucleosides
GB0814065D0 (en) Use of nucleoside analogs as anti-koi herpes virus molecules
EP2470194A4 (en) Novel nucleoside phosphonates and analogs
GB0717955D0 (en) Preparation of modified nucleosides
TH0901001785B (en) 1'-substituted carba-nucleoside analogs for antiviral therapy
GB0712770D0 (en) Anti-Koi herpes virus molecules
GB0809073D0 (en) Infection of cells by herpes simplex virus

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)